Mynephrocaps
NDC Package 58607-186-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Mynephrocaps is in the wasting syndrome in chronic renal failure; uremia; impaired metabolic functions of the kidney and to maintain levels when dietary intake of vitamins is inadequate or excretion or loss in excessive.Also, highly effective as a stress vitamin. Marketed by Martin Ekwealor Pharmaceuticals, Inc., this product is identified by NDC 58607-186.

Identification & Billing

NDC Package Code
58607-186-03
Package Description
100 CAPSULE in 1 BOTTLE
Product Code
58607-186
11-Digit Billing Format
58607018603
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
100 EA

Clinical Specifications

Proprietary Name
Mynephrocaps Dialysis/stress Vitamin Supplement
Dosage Form
-
Usage Information
In the wasting syndrome in chronic renal failure; uremia; impaired metabolic functions of the kidney and to maintain levels when dietary intake of vitamins is inadequate or excretion or loss in excessive.Also, highly effective as a stress vitamin.

Regulatory & Marketing

Labeler Name
Martin Ekwealor Pharmaceuticals, Inc.
Marketing Category
UNAPPROVED DRUG OTHER - An unapproved drug product in a marketing category that is not reflected on a particular list.
Start Marketing Date
12-16-2013
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 58607-186-03 identifies a specific commercial package of 100 capsule in 1 bottle of Mynephrocaps Dialysis/stress Vitamin Supplement, labeled by Martin Ekwealor Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 100 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Martin Ekwealor Pharmaceuticals, Inc. on December 16, 2013. The current certification is valid through December 31, 2017.

How is this Martin Ekwealor Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 58607018603. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 100 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
58607-186-03
11-Digit CMS (5-4-2)
58607-0186-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.